Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed2
Other1

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT06248177Not ApplicableCompleted
Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO).
Gastrointestinal SymptomsMicrobiotaProbiotic
StudychairStart date: 2024-01-16
NCT06313346Not ApplicableCompleted
Effect of a Probiotic on Microbiota Associated with the Immune System and Inflammation.
MicrobiotaProbiotic
StudychairStart date: 2024-01-08
NCT03183193Not ApplicableUnknown
Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO)
Non-Alcoholic Fatty Liver DiseaseObeseOverweight
StudychairStart date: 2016-06-01

Research Network

Collaboration Network

42 collaborators·54 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Santiago Navas-Carretero, PhD

University of Navarra

Moderately Similar
5 trials

Shared therapeutic areas:

Gastrointestinal SymptomsMicrobiotaOverweight+1 more

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de Navarra
Collaborated on 1 trial
Similarity Score44%

Fermín I Milagro Yoldi, PhD

University of Navarra

Moderately Similar
3 trials

Shared therapeutic areas:

MicrobiotaGastrointestinal SymptomsOverweight+1 more

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de Navarra
Collaborated on 1 trial
Similarity Score44%

Roncesvalles Garayoa, PhD

University of Navarra

Moderately Similar
2 trials

Shared therapeutic areas:

MicrobiotaProbioticsGastrointestinal Symptoms

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de Navarra
Collaborated on 2 trials
Similarity Score38%

Idoia Ibero-Baraibar, PhD

University of Navarra

Moderately Similar
3 trials

Shared therapeutic areas:

MicrobiotaProbioticsGastrointestinal Symptoms

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de Navarra
Collaborated on 2 trials
Similarity Score38%

María Goñi

University of Navarra

Moderately Similar
2 trials

Shared therapeutic areas:

MicrobiotaProbioticsGastrointestinal Symptoms

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de Navarra
Collaborated on 2 trials
Similarity Score38%

Gabriela Arias

University of Navarra

Moderately Similar
2 trials

Shared therapeutic areas:

MicrobiotaProbioticsGastrointestinal Symptoms

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de Navarra
Collaborated on 2 trials
Similarity Score38%

J. Ignacio Monreal, MD, PhD

Clinica Universidad de Navarra

Moderately Similar
1 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseObeseOverweight

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de NavarraComplejo Hospitalario de Navarra
Collaborated on 1 trial
Similarity Score34%

Jorge Quiroga, PhD

Clinica Universidad de Navarra

Moderately Similar
1 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseObeseOverweight

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de NavarraComplejo Hospitalario de Navarra
Collaborated on 1 trial
Similarity Score34%

M. Angeles Zulet, PhD

Centre for Nutrition Research, University of Navarra. CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III, Madrid, Spain

Moderately Similar
1 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseObeseOverweight

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de NavarraComplejo Hospitalario de Navarra
Collaborated on 1 trial
Similarity Score34%

Juan Uriz, PhD

Complejo Hospitalario de Navarra

Moderately Similar
1 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver DiseaseObeseOverweight

Worked with same sponsors:

Clinica Universidad de Navarra, Universidad de NavarraComplejo Hospitalario de Navarra
Collaborated on 1 trial
Similarity Score34%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06248177Not ApplicableStudyChair

Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO).

Gastrointestinal SymptomsMicrobiotaProbiotic
Completed
NCT06313346Not ApplicableStudyChair

Effect of a Probiotic on Microbiota Associated with the Immune System and Inflammation.

MicrobiotaProbiotic
Completed
NCT03183193Not ApplicableStudyChair

Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO)

Non-Alcoholic Fatty Liver DiseaseObeseOverweight
Unknown

All 3 trials loaded